Jefferson Life Sciences

← Back to your selection

All recorded activity

Rounds participated in: 3
Confirmed lead rounds: —
New companies: 3
Funding in participating rounds: $118.5M

By stage

Series B2

Series A1

By primary sector

Biotech2

Healthtech1

By country

United States2

United Kingdom1

Rounds

3 in all activity

Jul 14

Draig Therapeutics

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries B

Role not disclosed

Jun 10

FesariusTherapeutics

Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery

$20MSeries A

Role not disclosed

Jan 12

Juvena Therapeutics

Develops regenerative biologics to restore tissue function

$33.5MSeries B

Role not disclosed

← Back to your selection

All recorded activity

Rounds participated in: 3
Confirmed lead rounds: —
New companies: 3
Funding in participating rounds: $118.5M

By stage

Series B2

Series A1

By primary sector

Biotech2

Healthtech1

By country

United States2

United Kingdom1

Rounds

3 in all activity

Jul 14

Draig Therapeutics

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries B

Role not disclosed

Jun 10

FesariusTherapeutics

Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery

$20MSeries A

Role not disclosed

Jan 12

Juvena Therapeutics

Develops regenerative biologics to restore tissue function

$33.5MSeries B

Role not disclosed